1. Home
  2. TNXP vs PANL Comparison

TNXP vs PANL Comparison

Compare TNXP & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • PANL
  • Stock Information
  • Founded
  • TNXP 2007
  • PANL 1996
  • Country
  • TNXP United States
  • PANL United States
  • Employees
  • TNXP N/A
  • PANL N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • TNXP Health Care
  • PANL Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • PANL Nasdaq
  • Market Cap
  • TNXP 272.0M
  • PANL 287.4M
  • IPO Year
  • TNXP N/A
  • PANL N/A
  • Fundamental
  • Price
  • TNXP $35.48
  • PANL $5.14
  • Analyst Decision
  • TNXP Strong Buy
  • PANL
  • Analyst Count
  • TNXP 2
  • PANL 0
  • Target Price
  • TNXP $585.00
  • PANL N/A
  • AVG Volume (30 Days)
  • TNXP 729.5K
  • PANL 264.7K
  • Earning Date
  • TNXP 08-15-2025
  • PANL 08-07-2025
  • Dividend Yield
  • TNXP N/A
  • PANL 3.89%
  • EPS Growth
  • TNXP N/A
  • PANL N/A
  • EPS
  • TNXP N/A
  • PANL 0.30
  • Revenue
  • TNXP $10,041,000.00
  • PANL $554,589,579.00
  • Revenue This Year
  • TNXP $11.66
  • PANL $4.72
  • Revenue Next Year
  • TNXP $793.18
  • PANL $16.57
  • P/E Ratio
  • TNXP N/A
  • PANL $16.87
  • Revenue Growth
  • TNXP N/A
  • PANL 13.11
  • 52 Week Low
  • TNXP $6.76
  • PANL $3.93
  • 52 Week High
  • TNXP $130.00
  • PANL $8.00
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 52.96
  • PANL 64.20
  • Support Level
  • TNXP $33.71
  • PANL $4.58
  • Resistance Level
  • TNXP $38.13
  • PANL $5.07
  • Average True Range (ATR)
  • TNXP 2.62
  • PANL 0.19
  • MACD
  • TNXP -0.44
  • PANL 0.02
  • Stochastic Oscillator
  • TNXP 61.01
  • PANL 95.80

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: